MISSION REPORT: FOLLOW-UP VISIT ON HTA STUDIES IN INDONESIA IN FEBRUARY

The iDSI Indonesia project aims to institutionalize Health Technology Assessment in the country, to improve health system efficiency, and to prioritize interventions to ensure the longevity of the Universal Health Coverage Scheme or the Jaminan Kesehatan Nasional (JKN).
In continuing support towards the above-stated objectives, iDSI led by HITAP has been working closely with the Health Technology Assessment Committee (HTAC) – the nodal agency for HTA under the Ministry of Health, Indonesia and rendered assistance in three main areas, namely: building HTA infrastructure in the country, institutional strengthening and technical capacity building initiatives. Previously, i.e 2014 to 2016 or iDSI Phase I, HITAP supported completion of three HTA studies which have substantially contributed towards the making of a system of quality evidence base for policymakers in Indonesia. In contrast to Phase I, where the studies were supported by external donor agencies like PATH and ADP; Phase II was financially supported by the Badan Penyelenggara Jaminan Sosial (BPJS) the social insurance administrator in the country and led by the Health Technology Assessment Committee (HTAC).
February country visit (5 to 8 February 2018) is in alignment with the capacity building initiative, where the scholars receive hands-on training from globally acclaimed Thai experts on various aspects of economic evaluation. We are currently, providing technical support to the Indonesian team with four studies related to the evaluation of high-cost drugs.